Lanean...
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Patients with diabetes type 2 have an increased risk for cardiovascular disease and commonly use combination therapy consisting of the anti-diabetic drug metformin and a cholesterol-lowering statin. However, both drugs act on glucose and lipid metabolism which could lead to adverse effects when used...
Gorde:
| Argitaratua izan da: | Cardiovasc Diabetol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026339/ https://ncbi.nlm.nih.gov/pubmed/29960584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0738-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|